Our Team is Growing!
2 BRIDGE IS HIRING 2 Bridge is looking to strengthen its team with the following profiles: GxP Quality Manager CMC Clinical Trial Supply Manager CMC Junior Project Manager Early Development CMC Director Early Development For the detailed job description, go to the page ‘About us – Working for 2 Bridge’.
Upcoming Course – Key Considerations in Healthcare Product Development
An overview of the essential steps and key considerations A one-day course – 2nd March, 2023 at 2 Bridge office, Zoersel The healthcare sector is an ever changing environment. All elements in this ecosystem are constantly on the move: new insights in science and technology are only accelerating, leading to a vast number of innovations … Continue reading “Upcoming Course – Key Considerations in Healthcare Product Development”
Advanced Master in Biotech & Medtech Ventures – CEO interview
Today, 2 Bridge gives its first lecture in the Advanced Master in Biotech & Medtech Ventures program launched by I3h Institute and Solvay Lifelong Learning | Solvay Brussels School of Economics & Management! Talents are the future, and this Advanced Master is designed to train future life science entrepreneurs & leaders! 2 Bridge is happy … Continue reading “Advanced Master in Biotech & Medtech Ventures – CEO interview”
2 Bridge is 9 years old!
This week, 2 Bridge celebrates its 9th anniversary! Thank you to all the 2 Bridgers, clients, suppliers, and ecosystem partners for your continued support. Next year, in 2023, 2 Bridge turns 10 years old. To mark the special occasion, a lot of exciting campaigns are continuously coming. Are you ready? Stay tuned!
EU releases long-awaited GMP Annex 1 revision
After 14 years of development, the long-awaited revision of EU’s good manufacturing practice (GMP) Annex 1 for sterile drug products was released on 25 August 2022. The revised requirements, which are set to take effect on 25 August 2023, govern the manufacturing of sterile drugs made in the EU, as well as imported products. The … Continue reading “EU releases long-awaited GMP Annex 1 revision”
2 Bridge at Innovation for Health 2022
Excited to announce that 2 Bridge will be at Innovation for Health in RAI Amsterdam on 21 April 2022. Kevin Hollevoet, Ellen Voorspoels, Jannie Ausma, and Nancy Van Osselaer from our team will present and discuss how 2 Bridge can support advancing your healthcare product development and life sciences venture building. Are you also attending? Come and visit us at #Booth06!
2 Bridge Insights – Expert Insights on CMC Challenges
Last month, 2 Bridge welcomed two new colleagues to strengthen our venture building and CMC team. As part of the “2 Bridge Insights” series, we pulled together those two forward-thinking experts from small molecules, ATMP, venture building perspectives to share their insights on the current CMC (chemistry, manufacturing, and controls) challenges, adaptation, and solutions for … Continue reading “2 Bridge Insights – Expert Insights on CMC Challenges”
3 NEW COLLEAGUES ONBOARD
The first exciting news in 2022! 2 Bridge aims to build life sciences companies. We leverage our cross-functional teams and work together with investors, founders, and other stakeholders. We are proud to announce that three senior leaders are joining the 2 Bridge team to strengthen our know-how in health product development and venture building. Meet … Continue reading “3 NEW COLLEAGUES ONBOARD”
2 Bridge 2021 Highlights
As we are approaching the end of 2021, let’s look back at some of our achievements in the past year. Thanks to our fantastic team, 2021 is a fruitful year at 2 Bridge! More importantly, we wish you a healthy and happy holiday!
4 NEW COLLEAGUES ONBOARD
2 Bridge aims to build life sciences companies. We thereto leverage our cross-functional teams and work together with investors, founders, and other stakeholders. To fulfill that mission, we recently recruited strong leaders and upcoming talents that further strengthen our know-how in healthcare product development and venture building. We are very happy to announce 4 new … Continue reading “4 NEW COLLEAGUES ONBOARD”